1. Home
  2. ONEW vs STRO Comparison

ONEW vs STRO Comparison

Compare ONEW & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$9.15

Market Cap

158.8M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$14.88

Market Cap

332.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
STRO
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.8M
332.8M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
ONEW
STRO
Price
$9.15
$14.88
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$16.50
$31.33
AVG Volume (30 Days)
82.1K
253.7K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.77
N/A
Revenue
$1,872,334,000.00
$38,419,000.00
Revenue This Year
$0.30
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
$3.47
N/A
Revenue Growth
5.62
N/A
52 Week Low
$8.12
$0.72
52 Week High
$17.35
$43.85

Technical Indicators

Market Signals
Indicator
ONEW
STRO
Relative Strength Index (RSI) 25.94 20.09
Support Level $8.12 $12.85
Resistance Level $12.19 $17.33
Average True Range (ATR) 0.78 1.08
MACD -0.26 -0.31
Stochastic Oscillator 0.00 1.10

Price Performance

Historical Comparison
ONEW
STRO

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: